CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K12G3 Other 8-K12G3
- 4 Grant or award President and CEO acquired 177,239 shares (grant or award)
- 4 Grant or award Director acquired 5,304,490 shares (grant or award)
- 4 Grant or award Director acquired 1,980,538 shares (grant or award)
- 4 Grant or award CFO, Treasurer and Secretary acquired 87,126 shares (grant or award)
- 4 Grant or award Director acquired 19,176 shares (grant or award)
- 4 Grant or award Director acquired 7,034,520 shares (grant or award)
- 4 Grant or award Director acquired 7,578,095 shares (grant or award)
- 4 Grant or award Director acquired 2,382,108 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 35 of 71 · 1,401 filings